TITLE

INHALER DEVICES STILL A MAJOR HURDLE IN ASTHMA/COPD

PUB. DATE
July 2008
SOURCE
Worldwide Biotech;Jul2008, Vol. 20 Issue 7, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article discusses the advantages and disadvantages of inhaler devices in the treatment of asthma and COPD. Inhaler devices have a wide variation in design and method of delivery of the drug, making it difficult for patients to learn and use them correctly. It emphasizes the need to have a range of molecules available in the same device.
ACCESSION #
32848003

 

Related Articles

  • Formoterol Oral Inhalation.  // AHFS Consumer Medication Information;May2020, p1 

    Formoterol is used to treat wheezing, shortness of breath, and breathing difficulties caused by asthma and chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). It also is used to prevent breathing difficulties (bronchospasm)...

  • Levalbuterol Oral Inhalation.  // AHFS Consumer Medication Information;May2020, p1 

    Levalbuterol is used to prevent or relieve the wheezing, difficulty breathing, and chest tightness caused by lung disease such as asthma and chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways). Levalbuterol is in a class of medications called beta...

  • Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA²LEN) Braido, F.; Scichilone, N.; Lavorini, F.; Usmani, O. S.; Dubuske, L.; Boulet, L. P.; Mosges, R.; Nunes, C.; Sanchez-Borges, M.; Ansotegui, I. J.; Ebisawa, M.; Levi-Schaffer, F.; Rosenwasser, L. J.; Bousquet, J.; Zuberbier, T.; Canonica, G. Walter // World Allergy Organization Journal (BioMed Central);10/28/2016, Vol. 9, p1 

    Evidence that enables us to identify, assess, and access the small airways in asthma and chronic obstructive pulmonary disease (COPD) has led INTERASMA (Global Asthma Association) and WAO to take a position on the role of the small airways in these diseases. Starting from an extensive literature...

  • Long-Term Efficacy and Safety of Ipratropium Bromide plus Fenoterol via Respimat® Soft Mistâ„¢ Inhaler (SMI) versus a Pressurised Metered-Dose Inhaler in Asthma. Vincken, Walter; Bantje, Theo; Middle, Michelle V.; Gerken, Fronke; Moonen, Diane // Clinical Drug Investigation;2004, Vol. 24 Issue 1, p17 

    Objective: Respimat® Soft MistTM Inhaler (SMI) is a novel, propellant-free device that significantly increases lung deposition compared with pressurised metered-dose inhalers (pMDIs). The aim of this study was to compare the efficacy and safety of ipratropium bromide/fenoterol hydrobromide...

  • Qualitative assessment of attributes and ease of use of the ELLIPTATM dry powder inhaler for delivery of maintenance therapy for asthma and COPD. Svedsater, Henrik; Dale, Peter; Garrill, Karl; Walker, Richard; Woepse, Mark W. // BMC Pulmonary Medicine;2013, Vol. 13 Issue 1, p1 

    Background Medications for respiratory disorders including asthma and chronic obstructive pulmonary disease (COPD) are typically delivered to the lung by means of a handheld inhaler. Patient preference for and ability to use the inhaler may influence their adherence to maintenance therapy, and...

  • A new combination inhaler for asthma. McArthur, Ruth // Practice Nursing;Jul2008, Vol. 19 Issue 7, p350 

    The article focuses on the effectivity of the new combination corticosteroid inhaler Fostair in dealing with asthma in Great Britain. Fostair is an affordable pressurized metered-dose inhaler that has inhaled steroid and long acting corticosteroid used in dealing poor asthma control. A study...

  • Primer on inhalers and nebulizers. Salvo, Marissa; Barjami, Artild; Baughmaii-Oprica, Christopher // Drug Topics;Aug2015, Vol. 159 Issue 8, p38 

    With various delivery methods of asthma and chronic obstructive pulmonary disease (COPD) medications available, pharmacists need to be well versed on the administration and care instructions for each device. Inhaler technique varies depending on the device; therefore, patients may...

  • spacer device. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p702 

    An encyclopedia entry for "spacer device" is presented. It is a medical plastic device used for inhaler in order to facilitate delivery of medications for treating asthma and other lung conditions. It is designed for people who are having difficulty activating an inhaler where the drugs enter...

  • The adequacy of inhaler technique in patients with chronic obstructive pulmonary disease and asthma attending a tertiary care hospital in Navi Mumbai. Das, Akanksha; Uppe, Abhay; Sinha, Kanishk; T. K., Jayalakshmi; Nair, Girija; Nagpal, Amit // Indian Journal of Allergy Asthma & Immunology;Jul-Dec2016, Vol. 30 Issue 2, p95 

    Objectives: Chronic obstructive pulmonary disease (COPD) and asthma are major concerns to health-care system. Improper inhaler device used (metered dose inhaler/dry powder inhaler) is one of the major causes associated with inadequate control of the disease. This study was performed to evaluate...

  • Which Inhaler Combination is Best for COPD Treatment? Elliott, William T. // Internal Medicine Alert;4/15/2007, Vol. 29 Issue 7, p1 

    The article reports on studies which examined the effects of various inhaler combinations on the treatment of chronic obstructive pulmonary disease (COPD).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics